US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist

3.150
+0.040+1.29%

Close Feb 14 16:00 ET

3.150
0.0000.00%

Post 16:01 ET

266.06MMarket Cap-1.52P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Atea Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Nov 7, 2024	2024/Q3	0.000 / 0.000	--
Aug 7, 2024	2024/Q2	0.000 / 0.000	--
May 14, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Nov 7, 20242024/Q30.000 / 0.000--

Aug 7, 20242024/Q20.000 / 0.000--

May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Atea Pharmaceuticals Earnings Reports

Atea Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 22:38 ET

Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7, 2024 16:33 ET

Atea Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 16:52 ET

Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 7, 2024 16:23 ET